HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

EN3638

Also Known As:

6-hydroxyphthalaldehydic acid, O-(p-chlorobenzyl)oxime; benzoic acid, 2-((((4-chlorophenyl)methoxy)imino)methyl)-6-hydroxy-

Networked: 3 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Organic Chemicals: 133
- Amines: 4871
  - Hydroxylamines: 16
    - Oximes: 1292
      - EN3638: 3

Related Diseases

1.

Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental)

06/01/1980 - "Thymolytic doses of EN3638 were also immunosuppressive for experimental allergic encephalomyelitis (EAE). "
01/01/1979 - "Suppression of experimental allergic encephalomyelitis by EN3638: dependence on adjuvants and treatment schedules."
01/01/1979 - "Oral administration of 2, 3 or 4 doses of 100 or 250 mg/kg of EN3638 during the incubation period of experimental allergic encephalomyelitis delayed the onset and reduced the incidence and severity of clinical signs and histological lesions. "
02/01/1978 - "Suppression of experimental allergic encephalomyelitis by 6-hydroxyphthalaldehydic acid, O-(p-chlorobenzyl)oxime (EN3638)."

Related Drugs and Biologics

1.	EN3638

Related Therapies and Procedures

1.	Oral Administration